SK18172001A3 - Farmaceutické preparáty obsahujúce morfín a spôsoby ich intranazálneho podávania - Google Patents

Farmaceutické preparáty obsahujúce morfín a spôsoby ich intranazálneho podávania Download PDF

Info

Publication number
SK18172001A3
SK18172001A3 SK1817-2001A SK18172001A SK18172001A3 SK 18172001 A3 SK18172001 A3 SK 18172001A3 SK 18172001 A SK18172001 A SK 18172001A SK 18172001 A3 SK18172001 A3 SK 18172001A3
Authority
SK
Slovakia
Prior art keywords
morphine
pharmaceutically acceptable
acceptable salt
pharmaceutical preparation
combinations
Prior art date
Application number
SK1817-2001A
Other languages
English (en)
Slovak (sk)
Inventor
Raja G. Achari
Charanjit R. Behl
Jorge C. Demeireles
Ramneik Dua
Vincent D. - Romeo (Zosnul�)
Anthony P. Sileno
Original Assignee
Nastech Pharmaceutical Co., Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nastech Pharmaceutical Co., Inc. filed Critical Nastech Pharmaceutical Co., Inc.
Publication of SK18172001A3 publication Critical patent/SK18172001A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Otolaryngology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SK1817-2001A 1999-06-16 2000-05-23 Farmaceutické preparáty obsahujúce morfín a spôsoby ich intranazálneho podávania SK18172001A3 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33453799A 1999-06-16 1999-06-16
PCT/US2000/014157 WO2000076506A1 (fr) 1999-06-16 2000-05-23 Formulations pharmaceutiques et procedes comprenant de la morphine s'administrant par voie intra-nasale

Publications (1)

Publication Number Publication Date
SK18172001A3 true SK18172001A3 (sk) 2002-07-02

Family

ID=23307687

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1817-2001A SK18172001A3 (sk) 1999-06-16 2000-05-23 Farmaceutické preparáty obsahujúce morfín a spôsoby ich intranazálneho podávania

Country Status (30)

Country Link
US (1) US6677346B1 (fr)
EP (2) EP1183027A4 (fr)
JP (1) JP2003501467A (fr)
KR (1) KR20020016831A (fr)
AU (1) AU774175B2 (fr)
BG (1) BG106221A (fr)
BR (1) BR0012082A (fr)
CA (1) CA2374877C (fr)
CZ (1) CZ20014399A3 (fr)
DE (1) DE10084709T1 (fr)
DK (1) DK200101859A (fr)
EE (1) EE200100677A (fr)
ES (1) ES2197792B1 (fr)
FI (1) FI20012462A7 (fr)
GB (1) GB2367005A (fr)
HR (1) HRP20010926A2 (fr)
HU (1) HUP0201856A3 (fr)
IS (1) IS6202A (fr)
LT (1) LT4976B (fr)
LU (1) LU90859B1 (fr)
LV (1) LV12859B (fr)
MX (1) MXPA01012879A (fr)
NO (1) NO20015931L (fr)
NZ (1) NZ515783A (fr)
PL (1) PL352556A1 (fr)
SE (1) SE0104203D0 (fr)
SI (1) SI20850A (fr)
SK (1) SK18172001A3 (fr)
TR (1) TR200103613T2 (fr)
WO (1) WO2000076506A1 (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9924797D0 (en) 1999-10-20 1999-12-22 West Pharm Serv Drug Res Ltd Compound
US20040115133A1 (en) * 2000-05-10 2004-06-17 Wermeling Daniel P. Intranasal opioid compositions
US20060083691A1 (en) * 2000-05-10 2006-04-20 Wermeling Daniel P Intranasal opioid compositions, delivery devices and methods of using same
EP1328214A4 (fr) * 2000-09-20 2009-07-29 Shahinian Lee Jr Preparations et medications nasales, inhalables et ophtalmiques locales a conservation spontanee
WO2003002071A2 (fr) * 2001-06-29 2003-01-09 Lewandowski Leon J Therapie de sevrage individualisee en cas de dependance
GB0210264D0 (en) * 2002-05-03 2002-06-12 Arakis Ltd The treatment of pain and migraine headache
US20040102476A1 (en) * 2002-11-25 2004-05-27 Chan Tai Wah High concentration formulations of opioids and opioid derivatives
US20050175679A1 (en) * 2004-02-10 2005-08-11 Michael Moshman Controlled release formulations
US9895444B2 (en) 2004-08-25 2018-02-20 Aegis Therapeutics, Llc Compositions for drug administration
US20140162965A1 (en) 2004-08-25 2014-06-12 Aegis Therapeutics, Inc. Compositions for oral drug administration
JP5607291B2 (ja) 2004-11-24 2014-10-15 メダ ファーマシューティカルズ インコーポレイテッド アゼラスチンを含む組成物およびその使用方法
US9415034B2 (en) * 2005-01-05 2016-08-16 National Defense Medical Center Inhibitors and enhancers of uridine diphosphate-glucuronosyltransferase 2B (UGT2B)
ES2277743B2 (es) 2005-06-02 2008-12-16 Universidade De Santiago De Compostela Nanoparticulas que comprenden quitosano y ciclodextrina.
JP5276982B2 (ja) 2005-08-26 2013-08-28 ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティ オキシトシンの投与による頭痛の処置のための方法
US20070212307A1 (en) * 2006-02-10 2007-09-13 Daniel Wermeling Pharmaceutical Compositions Comprising an Opioid Receptor Antagonist and Methods of Using Same
US8226949B2 (en) 2006-06-23 2012-07-24 Aegis Therapeutics Llc Stabilizing alkylglycoside compositions and methods thereof
US8389014B2 (en) * 2006-12-22 2013-03-05 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Gel useful for the delivery of ophthalmic drugs
GB2477545B (en) * 2010-02-05 2011-12-21 Special Products Ltd A liquid morphine composition for buccal administration
MY194947A (en) 2011-05-13 2022-12-27 Euro Celtique Sa Intranasal pharmaceutical dosage forms comprising naloxone
CA2881158A1 (fr) 2012-07-26 2014-01-30 Wockhardt Limited Composition pharmaceutique comprenant de la diamorphine destinee a une administration intranasale
WO2015095389A1 (fr) * 2013-12-18 2015-06-25 Aegis Therapeutics, Llc Compositions pour administration de médicaments
US11135155B2 (en) 2014-07-08 2021-10-05 Hikma Pharmaceuticals Usa Inc. Liquid naloxone spray
SG11201705591PA (en) 2015-01-07 2017-08-30 Trigemina Inc Magnesium-containing oxytocin formulations and methods of use
JP7093559B2 (ja) 2016-04-12 2022-06-30 トライジェミナ， インコーポレイテッド マグネシウム含有オキシトシン製剤および使用の方法
EP3528873A2 (fr) * 2016-10-21 2019-08-28 Somniferum Labs LLC Méthode, système et appareil pour l'administration contrôlée d'opioïde et d'autres médicaments
EP3697381B1 (fr) * 2017-10-20 2023-06-07 Chiesi Farmaceutici S.p.A. Formulations pharmaceutiques comprenant des agonistes de récepteurs opioïdes comme ingrédients actifs, leurs procédés de fabrication et leurs utilisations thérapeutiques
WO2019157099A1 (fr) 2018-02-06 2019-08-15 Aegis Therapeutics, Llc Formulations d'épinéphrine intranasale et méthodes de traitement d'une maladie
CN115804754A (zh) * 2022-12-16 2023-03-17 广州新济药业科技有限公司 吗啡鼻喷剂及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4464378A (en) * 1981-04-28 1984-08-07 University Of Kentucky Research Foundation Method of administering narcotic antagonists and analgesics and novel dosage forms containing same
US4464376A (en) 1982-07-22 1984-08-07 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
GB8514665D0 (en) * 1985-06-11 1985-07-10 Eroceltique Sa Oral pharmaceutical composition
US5202128A (en) 1989-01-06 1993-04-13 F. H. Faulding & Co. Limited Sustained release pharmaceutical composition
GB9202464D0 (en) * 1992-02-05 1992-03-18 Danbiosyst Uk Composition for nasal administration
ATE290864T1 (de) * 1993-03-26 2005-04-15 Franciscus Wilhelmus He Merkus Pharmazeutische zusammensetzungen zur intranasalen verabreichung von dihydroergotamin
GB9426102D0 (en) 1994-12-23 1995-02-22 Merck Sharp & Dohme Pharmacuetical compositions
WO1998013001A1 (fr) * 1996-09-27 1998-04-02 Nastech Pharmaceutical Company, Inc. Formulations intranasales pour favoriser le sommeil et leur procede d'utilisation

Also Published As

Publication number Publication date
LV12859B (en) 2002-12-20
JP2003501467A (ja) 2003-01-14
IS6202A (is) 2001-12-14
HRP20010926A2 (en) 2003-04-30
SI20850A (sl) 2002-10-31
LT2001119A (en) 2002-07-25
EE200100677A (et) 2003-02-17
GB2367005A (en) 2002-03-27
BR0012082A (pt) 2002-05-07
ES2197792A1 (es) 2004-01-01
DK200101859A (da) 2001-12-12
CA2374877C (fr) 2004-04-13
MXPA01012879A (es) 2003-06-24
HUP0201856A1 (en) 2002-09-28
WO2000076506A1 (fr) 2000-12-21
HUP0201856A3 (en) 2004-12-28
CZ20014399A3 (cs) 2002-06-12
ES2197792B1 (es) 2005-05-01
AU5156100A (en) 2001-01-02
SE0104203L (sv) 2001-12-14
CA2374877A1 (fr) 2000-12-21
TR200103613T2 (tr) 2004-08-23
NO20015931D0 (no) 2001-12-04
FI20012462L (fi) 2002-01-16
GB0128383D0 (en) 2002-01-16
EP1183027A4 (fr) 2003-02-05
NO20015931L (no) 2002-02-08
PL352556A1 (en) 2003-08-25
DE10084709T1 (de) 2002-09-26
EP1183027A1 (fr) 2002-03-06
AU774175B2 (en) 2004-06-17
FI20012462A7 (fi) 2002-01-16
LT4976B (lt) 2002-12-30
SE0104203D0 (sv) 2001-12-14
NZ515783A (en) 2004-05-28
LU90859B1 (en) 2002-01-24
KR20020016831A (ko) 2002-03-06
BG106221A (bg) 2002-08-30
US6677346B1 (en) 2004-01-13
EP1419774A1 (fr) 2004-05-19

Similar Documents

Publication Publication Date Title
SK18172001A3 (sk) Farmaceutické preparáty obsahujúce morfín a spôsoby ich intranazálneho podávania
AU775112B2 (en) Compositions and methods comprising morphine gluconate
JP2003501468A (ja) アポモルヒネの経鼻送達
NZ213067A (en) Composition for transdermal delivery of opioids
EP1137398B1 (fr) Preparation pharmaceutique pour inhalation d'un opioide
SK12682003A3 (sk) Prípravky obsahujúce imidazotriazinón na nazálnu aplikáciu
US10874658B2 (en) Sublingual opioid formulations containing naloxone
EP3897577A1 (fr) Formulation intranasale
CA2552909C (fr) Medicament destine a etre administre a des animaux par voie topique
BG62197B1 (bg) Антимигренно средство за интраназално приложение
HK1062812A (en) Pharmaceutical formulations and methods comprising intranasal morphine
WO2000076507A1 (fr) Methode permettant d'ameliorer la solubilite de la morphine et de compositions pharmaceutiques a base de morphine
WO2000076477A1 (fr) Methodes et compositions permettant de traiter la douleur incidente
JP2002516815A (ja) スコポラミンを含有する経鼻調合物と動揺病の治療法